Defence Therapeutics - Science community sees potential for "treating a broad range of cancers"

Scientific findings gain significance when validated and discussed by independent researchers. Defence Therapeutics' technology recently received funding and expert endorsement from Canadian biotech funder CQDM, which is funded by numerous industry multinationals, among others. We look at what the collaboration could mean for Defence Therapeutics, why nasal spray as chemotherapy is increasingly likely, and why Defence's technology portfolio fits the bill right now in what analysts expect to be a wave of acquisitions in the biotech sector.

Den vollständigen Artikel lesen ...